Not exact matches
«
Pancreatic cancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU La
cancer cells are deadly because they
program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU L
program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the
Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU La
Cancer Immunology
Program at Perlmutter and vice chair for research in the Department of Surgery at NYU L
Program at Perlmutter and vice chair for
research in the Department of Surgery at NYU Langone.
«As someone who
researches pancreatic cancer, I think this discovery is significant because it defines mechanisms that lead to this cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Inst
cancer, I think this discovery is significant because it defines mechanisms that lead to this
cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Inst
cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas
Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Inst
Cancer Research Program and Experimental Therapeutics
Program at the University of Utah's Huntsman
Cancer Inst
Cancer Institute.
The
research team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer In
research team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in
Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer
Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inst
Cancer, one of three
cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inst
cancer centers in the U.S. to receive a Specialized
Program of
Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer In
Research Excellence (SPORE) grant for
pancreatic cancer from the National Cancer
pancreatic cancer from the National Cancer Inst
cancer from the National
Cancer Inst
Cancer Institute.
Does the World
Pancreatic Cancer Coalition raise money to fund research or other programs, like patient services for pancreat
Pancreatic Cancer Coalition raise money to fund research or other programs, like patient services for pancreatic c
Cancer Coalition raise money to fund
research or other
programs, like patient services for
pancreaticpancreatic cancercancer?
The World
Pancreatic Cancer Coalition is not a legal entity and does not raise money to fund research or programs for pancreat
Pancreatic Cancer Coalition is not a legal entity and does not raise money to fund research or programs for pancreatic c
Cancer Coalition is not a legal entity and does not raise money to fund
research or
programs for
pancreaticpancreatic cancercancer.
Spotlight on Middlesex County — April 2017 Rutgers
Cancer Institute of New Jersey's Dr. Darren Carpizo, director of the Liver
Cancer and Bile Duct Oncology
Program and a member of the Gastrointestinal / Hepatabiliary Oncology
Program, gives a tour of his lab to Middlesex County Freeholder Director Ronald Rios, and discusses
pancreatic research being conducted there.
Penn Medicine's
Pancreatic Cancer Research Center is a leading edge, translational research program that combines basic science research and clinical invest
Research Center is a leading edge, translational
research program that combines basic science research and clinical invest
research program that combines basic science
research and clinical invest
research and clinical investigation.
Heather Schofield, an M.D. / Ph.D. candidate in the Cellular and Molecular Biology
Program, collected the image from a mouse model while conducting
pancreatic cancer research.